Eva Ulbrich

537 citations
11 papers · 432 indexed · h-index 10

Eva Ulbrich

11 papers receiving 420 citations

Peers

Eva Ulbrich
Comparison fields: 5 of 63
  • Oncology 185
  • Physiology 29
  • Cell Biology 75
  • Cancer Research 57
  • Immunology 80
Replace Bélinda Duchêne with:
Bélinda Duchêne France
Iris Treinies Germany
Hyun-Jin Shin South Korea
Nicole Malet France
Jakob Vejby Larsen Denmark
Ralitsa R. Madsen United Kingdom
Giuseppina D’Andrilli Italy
Jenna D. Lovaas United States
Uschi Braun United States
Eva Ulbrich relative to Bélinda Duchêne France Bélinda Duchêne's profile →
Citations per field
00.5×1.5×2.5×
Bélinda Duchêne · 1×
Citations per year

Countries citing papers authored by Eva Ulbrich

Since Specialization
Citations

This map shows the geographic impact of Eva Ulbrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Ulbrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Ulbrich more than expected).

Fields of papers citing papers by Eva Ulbrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Ulbrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Ulbrich. The network helps show where Eva Ulbrich may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Eva Ulbrich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eva Ulbrich Line = papers co-authored together Eva Ulbrich links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1
Come to STEAM. We have cookies
20201
2 200737
3
Prognostic impact of haemoglobin levels in breast cancer.
200721
4 200520
5 2004117
6 200415
7
Serum parameters of iron metabolism in patients with breast cancer.
200413
8 200415
9 200481
10 199992
11 199820

About Eva Ulbrich

Eva Ulbrich is a scholar working on Oncology, Hematology, Immunology and Allergy, Dermatology and Genetics, having authored 11 papers that have together received 432 indexed citations. Recurring topics across this work include Bone health and treatments (2 papers), TGF-β signaling in diseases (2 papers), Genomic variations and chromosomal abnormalities (2 papers), Bone Metabolism and Diseases (2 papers), Sympathectomy and Hyperhidrosis Treatments (1 paper), Genetic Syndromes and Imprinting (1 paper), Erythropoietin and Anemia Treatment (1 paper) and Estrogen and related hormone effects (1 paper). The work is most often cited by research in Oncology (185 citations), Physiology (29 citations), Cell Biology (75 citations), Cancer Research (57 citations) and Immunology (80 citations). Eva Ulbrich has collaborated with scholars based in Germany, Austria and Australia. Frequent co-authors include Heinz Koelbl, Antje Lebrecht, Lukas Hefler, Christoph Grimm, Tilmann Lantzsch, Elisabeth Ludwig, Kurt Von Figura, Regina Pohlmann, Angela Hafner and Frank Dittmer. Their work appears in journals such as The International Journal of Biological Markers, Cancer, American Journal Of Pathology, Journal of Cell Science and Transgenic Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026